SALT LAKE CITY, June 5, 2018 —Clinical Innovations, one of the world’s largest medical device companies focused on labor and delivery and neonatal intensive care, has acquired Australian distributor JB Medical Supplies.
The deal strengthens Clinical Innovations’ position in the sizable Australian market and supports the company’s broader global growth strategy. JB Medical Supplies, Australia’s leading obstetrics distributor, will operate as a wholly owned subsidiary of Clinical Innovations.
The Salt Lake City company bought JB Medical Supplies from the family of the late Dr. Aldo Vacca, a trailblazer in the vacuum method for operative vaginal delivery, a technology used in about 10 percent of births globally and a key component of the Clinical Innovations product offering. More than 10 million of the company’s Kiwi® Vacuum Assisted Delivery System devices have been deployed worldwide.
“The Vacca family is a leader in the world of obstetrics whose work has improved the lives of countless mothers and babies across the globe,” said Ken Reali, president and CEO of Clinical Innovations. “Partnering with them on this deal is an honor and having JB Medical as part of our company will accelerate our growth in Australia.”
With market-leading products such as the ebb® Complete Tamponade System, traxi® Panniculus Retractor and babyLance™ safety heel stick, Clinical Innovations has a presence in more than 90 countries. The company has quickly grown its global footprint in recent years, expanding to new territories, including underserved markets in Southeast Asia.
JB Medical Supplies, which offers customers innovative products as well as support services aimed at ensuring clinician confidence and optimal patient outcomes, will continue to be led by CEO John Gairns.
“I am thrilled to work with the Clinical Innovations team,” Gairns said. “Being part of one of the world leaders in obstetrical and neonatal care will add to the JB Medical growth strategy.”
“Through John’s dedication and the tireless efforts of his entire team, JB Medical has built a world-class operation with a philosophy that’s perfectly in-sync with the way we do business,” said Steve Cash, senior vice president of global sales at Clinical Innovations. “We’ve long enjoyed a tremendous relationship, and this acquisition will allow us all to accomplish even more.”
Clinical Innovations is owned by EQT, a leading investment firm with approximately EUR 50 billion in raised capital across 27 funds. Formed in 1993, Clinical Innovations is celebrating its quarter-century anniversary throughout 2018.
About Clinical Innovations
Clinical Innovations is one of the largest medical device companies exclusively focused on labor and delivery and the neonatal intensive care unit. The company is a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter; Kiwi® Vacuum-Assisted Delivery System; ROM Plus® Rupture of Membranes Test; traxi® Panniculus Retractor, ClearView Uterine Manipulator, the babyLance Safety heel stick and the recently added ebb Complete Tamponade System. Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is an EQT company. For more information, visit clinicalinnovations.com.
About JB Medical Supplies
JB Medical Supplies is the leading obstetrics distributor in Australia, supplying leading-edge products used in labor, delivery and perinatal care. The company goes beyond simple supply, developing its customers’ clinical understanding of products to ensure clinician confidence and optimal patient outcomes. For more information, visit jbmedicalsupplies.com.au.
EQT is a leading investment firm with approximately EUR 49 billion in raised capital across 26 funds.
EQT is an active investor and owner in the health care sector, including investments in Certara, Press Ganey, Ottobock, Sivantos, and Lima. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. For more information, visit EQTpartners.com.